Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Philip J. Chang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-1194-5440; OpenAlex author ID A5043714287. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 trial · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 2

  1. Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630. Co-author DOI 10.3390/cancers18050789↗
  2. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Co-author DOI 10.3390/cancers17040630↗

Trials 1

  1. A Supervised Prehabilitation Program for Patients With Pancreatic Cancer Principal investigator NCT05692323↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. An Ngo‐Huang · 2 shared papers, 2025–2026 · strength 0.62
  2. Nathan H. Parker · 2 shared papers, 2025–2026 · strength 0.62
  3. Andrew Eugene Hendifar · 2 shared papers, 2025–2026 · strength 0.62
  4. Andrew L. Coveler · 2 shared papers, 2025–2026 · strength 0.62
  5. Gillian K. Gresham · 2 shared papers, 2025–2026 · strength 0.62
  6. Paul E. Oberstein · 2 shared papers, 2025–2026 · strength 0.62

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.